PollNowData
Back to companies

AIM ImmunoTech Inc.

AIMUSNYSEPharmaceuticals & Healthcare

AIM ImmunoTech Inc.

Revenue
$88,000
YoY -48.2%
Operating income
-$11.7mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API